Epidemic hepatitis B caused by commercial human immunoglobulin.
An epidemic of acute hepatitis B followed the administration of human immunoglobulin to members of the staff of a mission hospital in India and their families. Jaundice developed in 123 (38%) of 325 persons inoculated. Hepatitis-B surface antigen was detected in three of the batches of immunoglobulin which were available for testing.
D003378:Counterimmunoelectrophoresis; D004196:Disease Outbreaks / Q000453:epidemiology*; D006509:Hepatitis B / Q000453:epidemiology / Q000209:etiology* / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007194:India
D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins